Quick Answer
PureTech Health plc reported R&D Expense of $69.45 million for fiscal year 2024.
PureTech Health plc R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $69.45M | -27.8% |
| 2023 | $96.23M | -36.9% |
| 2022 | $152.43M | +38.0% |
| 2021 | $110.47M | +35.0% |
| 2020 | $81.86M | -4.6% |
| 2019 | $85.85M | +10.9% |
| 2018 | $77.40M | — |
- PureTech Health plc showed a decrease of -27.8% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2024 period, PureTech Health plc’s r&d expense has declined by 10.3% (from $77.40 million to $69.45 million).
- The most recent figure is from PureTech Health plc’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: